Endocrinología, Diabetes y Nutrición

(JIF 2023)

-Alcubierre N, Granado M, Bogdanov P, Hernandez C, Ramos H, Castelblanco E, Real J, Rubinat E, Traveset A, Hernandez M, Jurjo C, Vioque J, Navarrete EM, Simo R, Mauricio D. Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies. Nutrients. 2023; 15(5):1169. DOI:10.3390/nu15051169. PMID:36904168. IF:4,800 (Q1/2D). Document type: Article.

-Ampudia FJ, Ugarte E, Chico A, García J, Galan M. Spanish Consensus on the Use of isCGM in the Management of Patients With Insulin Therapy: The MONITOR Project. Journal Of Diabetes Science And Technology. 2023; 17(5):19322968221087270. DOI:10.1177/19322968221087270. PMID:35466722. IF:4,100 (Q2/3D). Document type: Article.

-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Endocrinologia Diabetes y Nutricion. 2023; 70(7). DOI:10.1016/j.endinu.2023.02.002. IF:1,800 (Q3/8D). Document type: Article.

-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Cirugia Cardiovascular. 2023; 30(3). DOI:10.1016/j.circv.2023.02.001. IF:0,300 (Q4/10D). Document type: Article.

-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. Rec: Cardioclinics. 2023; 58(2). DOI:10.1016/j.rccl.2022.11.004. Document type: Article.

-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. REVISTA CLINICA ESPANOLA. 2023; 223(7). DOI:10.1016/j.rce.2022.11.001. PMID:37302464. IF:2,300 (Q2/3D). Document type: Article.

-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿qué parámetros debe incluir un perfil lipídico básico?. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2023; 4(2). DOI:10.1515/almed-2023-0010. IF:1,100 (Q4/8D). Document type: Article.

-Battelino T, Alexander CM, Amiel SA, Arreaza G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes & Endocrinology. 2023; 11(1). DOI:10.1016/S2213-8587(22)00319-9. PMID:36493795. IF:44,000 (Q1/1D). Document type: Review.

-Bellido V, Freckman G, Pérez A, Galindo RJ. Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital. Endocrine Practice. 2023; 29(11). DOI:10.1016/j.eprac.2023.06.007. PMID:37369291. IF:3,700 (Q2/4D). Document type: Review.

-Bellon F, Solà I, Gimenez G, Hernández M, Metzendorf MI, Rubinata E, Mauricio D. Perioperative glycaemic control for people with diabetes undergoing surgery. Cochrane Database of Systematic Reviews. 2023; (8):CD007315. DOI:10.1002/14651858.CD007315.pub3. PMID:37526194. IF:8,800 (Q1/1D). Document type: Review.

-Bermudez M, Marti M, Castro E, Bretones MD, Farras C, Gonzalez J, Pamplona R, Lecube A, Mauricio D, Cambray S, Valdivielso JM, Fernandez E, ILERVAS C. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study. ATHEROSCLEROSIS. 2023; 375. DOI:10.1016/j.atherosclerosis.2023.05.002. PMID:37276714. IF:4,900 (Q1/2D). Document type: Article.

-Bundo M, Vlacho B, Llussa J, Bobe I, Aivar M, Ciria C, Martinez A, Real J, Mata M, Cos X, Doria M, Viade J, Franch J, Mauricio D. Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study. Journal of Foot and Ankle Research. 2023; 16(1):8. DOI:10.1186/s13047-023-00602-6. PMID:36849888. IF:2,500 (Q1/3D). Document type: Article.

-Canyelles M, Blanco F, Pérez A, Escolà JC. Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2  Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care  2023;46:305-312. DIABETES CARE. 2023; 46(10):e203. DOI:10.2337/dc23-0774. PMID:37729500. IF:14,800 (Q1/1D). Document type: Letter.

-Chico A, de Solis SN, Lainez M, Rius F, Cuesta M. Efficacy, Safety, and Satisfaction with the Accu-Chek Insight with Diabeloop Closed-Loop System in Subjects with Type 1 Diabetes: A Multicenter Real-World Study. Diabetes Technology & Therapeutics. 2023; 25(4). DOI:10.1089/dia.2022.0449. PMID:36724301. IF:5,700 (Q1/2D). Document type: Article.

-Chico A, Moreno J, Fernández D, Solá E. The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization. Diabetes Therapy. 2023; 15(1). DOI:10.1007/s13300-023-01486-2. PMID:37857988. IF:2,800 (Q3/6D). Document type: Article.

-Corral M, Arpa B, Rosell E, Egia L, Mora C, Stratmann T, Sanchez A, Casanovas A, Esquerda JE, Mauricio D, Vives M, Verdaguer J. NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development. Frontiers in Endocrinology. 2023; 14:1176566. DOI:10.3389/fendo.2023.1176566. PMID:37334284. IF:3,900 (Q2/3D). Document type: Article.

-Dieberger AM, Obermayer B, Harreiter J, Desoye G, van MNM, Simmons D, Corcoy R, Perez JMA, Kautzky A, Damm P, Mathiesen E, Jensen DM, Andersen LLT, Dunne F, Lapolla A, Dalfra MG, Bertolotto A, Jelsma JGM, Galjaard S, Wender E, Zawiejska A, Hill D, Devlieger R, Snoek FJ, DALI Core Investigator G. Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study. INTERNATIONAL JOURNAL OF OBESITY. 2023; 47(9). DOI:10.1038/s41366-023-01347-9. PMID:37500924. IF:4,200 (Q1/3D). Document type: Article.

-Escalada J, Pérez A, Rica I. Is the Spanish type 1 diabetes mellitus registry really necessary?. Endocrinologia Diabetes y Nutricion. 2023; 70(10). DOI:10.1016/j.endinu.2023.05.002. PMID:38000969. IF:1,800 (Q3/8D). Document type: Article.

-Falkenhain D, Muniesa C, Estrach MT, Morillo M, Peñate Y, Acebo E, Pujol RM, García MP, Machan S, Medina S, Botella R, Fernández de Misa R, Blanes M, Flórez A, Pérez G, Izu R, Yanguas I, Silva E, Pérez A, Prieto L, Zayas A, Parera ME, Pérez A, Aspe L, Román C, Sánchez MP, Bassas J, Domínguez JD, Calzado L, Navedo M, Ortiz A, Servitje O, Polo I, Torres I, Hernández MN, Mitxelena J, García A, García I, Ortiz PL. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and  Venereology (AEDV): Data for the First 5 Years. Actas Dermo-Sifiliograficas. 2023; 114(4). DOI:10.1016/j.ad.2022.11.010. PMID:36529273. IF:3,800 (Q1/2D). Document type: Article.

-Frontino G, Succurro E, Corcoy R, Scialabba F, Poloniato A, Scavini M. Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes. Frontiers in Endocrinology. 2023; 14:1270472. DOI:10.3389/fendo.2023.1270472. PMID:38098867. IF:3,900 (Q2/3D). Document type: Editorial Material.

-García A, Balsells M, Solà I, Gich I, Corcoy R. Impact of gestational diabetes mellitus treatment on medium/long-term outcomes after pregnancy: A systematic review and meta-analysis. DIABETIC MEDICINE. 2023; 40(1):e14998. DOI:10.1111/dme.14998. PMID:36326694. IF:3,200 (Q2/5D). Document type: Article.

-García E, Gil P, Miñambres I, Benitez A, Rodríguez C, Claudi L, Julve J, Benitez S, Sánchez JL, Rives J, Garcia X, Vilades D, Perez A, Llorente V. Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control. Frontiers in Endocrinology. 2023; 14:1236487. DOI:10.3389/fendo.2023.1236487. PMID:37635956. IF:3,900 (Q2/3D). Document type: Article.

-Genua I, Iruzubieta P, Rodríguez JC, Pérez A, Crespo J. NAFLD and type 2 diabetes: A practical guide for the joint management. Gastroenterologia y Hepatologia. 2023; 46(10). DOI:10.1016/j.gastrohep.2022.12.002. PMID:36584750. IF:2,200 (Q3/6D). Document type: Review.

-Giannella A, Castelblanco E, Zambon CF, Basso D, Hernandez M, Ortega E, Alonso N, Mauricio D, Avogaro A, Ceolotto G, Vigili de Kreutzenberg S. Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. DIABETES CARE. 2023; 46(3). DOI:10.2337/dc22-1441. PMID:36577032. IF:14,800 (Q1/1D). Document type: Article.

-Giménez G, Vinals C, Mata M, Vlacho B, Real J, Franch J, Ortega E, Mauricio D. Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia. Cardiovascular Diabetology. 2023; 22(1):179. DOI:10.1186/s12933-023-01917-1. PMID:37452416. IF:8,500 (Q1/1D). Document type: Article.

-Goh SY, Kosiborod MN, Lam CSP, Cavender MA, Kohsaka S, Norhammar A, Birkeland KI, Holl RW, Mauricio D, Tangri N, Shaw JE, Thuresson M, Fenici P, Kim DJ, REAL Investigators Study CVDGRP. Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study. DIABETES OBESITY & METABOLISM. 2023; 25(8). DOI:10.1111/dom.15092. PMID:37055714. IF:5,400 (Q1/2D). Document type: Letter.

-Gomez F, Menendez E, Conde S, Conget I, Novials A, Olmedo IS, Tinahones F, San Laureano FC, de la Torre ML, Carazo AM, Hospital J, Nivela OB, Menendez E, Cosmas LM, Payeras F, Gomez IL, Bayo J, Montalban C, Gomez F, de Luis D, Diaz G, Lopez A, Santos E, Jimenez LML, Alvarez V, Samper BB, Ballesteros AC, Gomez BD, Conget I, Perez M, Soldevila B, Flores IC, Garcia MH, Ricart W, Colet AM, Biescas EC, Ampudia FJ, Hernandez A, Sanchez C, Pico A, Escribano JRD, Montanana CF, Pedro T, Abellan P, Rossetti P, Morales FM, Enciso F, Gonzalez AS, Guerrero DB, Cano RL, Lopez JMG, Melero V, Martin J, Mira SA, Serrano MB, Sanfiel MB, Pascual AC, Gomez FJD, Fernandez M, Illan F, Martinez A, Llenas LF, Gaztambide S, Gomez CRF, Oleaga A, de Salinas M, Lopez JP, Gomez AL, Sancho A, Lozano MF, Galan IR, Caimari M, Cardona R, Leon MC, Gonzalez GC, Diez F, Rodriguez PC, Roldan B, del Villar NGP, Perez PR, Rica I, Lopez ID, SED SED1 Study I. Physical activity patterns in type 1 diabetes in Spain: The SED1 study. BMC Sports Science Medicine and Rehabilitation. 2023; 15(1):92. DOI:10.1186/s13102-023-00695-3. PMID:37491278. IF:2,100 (Q1/3D). Document type: Article.

-Gracia A, Lopez A, Lazaro JL, Perez A, Pomares FJ, Fernandez LM, Gil VF, Chicharro E. Consensus-based recommendations on physical activity and exercise in patients with diabetes at risk of foot ulcerations: a Delphi study. Brazilian Journal of Physical Therapy. 2023; 27(2):100500. DOI:10.1016/j.bjpt.2023.100500. PMID:37079949. IF:3,100 (Q1/1D). Document type: Article.

-Iruzubieta P, Bataller R, Arias MT, Arrese M, Calleja JL, Castro G, Cusi K, Dillon JF, Martinez ML, Mateo M, Perez A, Rinella ME, Romero M, Schattenberg JM, Zelber S, Crespo J, Lazarus JV. Research Priorities for Precision Medicine in NAFLD. Clinics in Liver Disease. 2023; 27(2). DOI:10.1016/j.cld.2023.01.016. PMID:37024222. IF:2,900 (Q2/5D). Document type: Article.

-Jayaraman S, Pérez A, Miñambres I, Sánchez JL, Gursky O. LDL binding to cell receptors and extracellular matrix is proatherogenic in  obesity but improves after bariatric surgery. JOURNAL OF LIPID RESEARCH. 2023; 64(11):100451. DOI:10.1016/j.jlr.2023.100451. PMID:37777014. IF:5,000 (Q1/3D). Document type: Article.

-Julián MT, Ballesta S, Pera G, Pérez A, Soldevila B, Caballería L, Morillas R, Expósito C, Martínez–Escudé A, Puig M, Franch J, Torán P, Cusi K, Julve J, Mauricio D, Alonso N. Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study. Frontiers in Endocrinology. 2023; 13:1051958. DOI:10.3389/fendo.2022.1051958. PMID:36714592. IF:3,900 (Q2/3D). Document type: Article.

-Julve J, Genua I, Quifer P, Yanes O, Barranco M, Hernandez M, Junza A, Capellades J, Granado M, Alonso N, Castelblanco E, Mauricio D. Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2023; 197:110578. DOI:10.1016/j.diabres.2023.110578. PMID:36804334. IF:6,100 (Q1/2D). Document type: Article.

-Ling S, Zaccardi F, Vlacho B, Li P, Gatius JR, Mata M, Franch J, Kosiborod MN, Gillies C, Fenici P, Mauricio D, Shah BR, Khunti K. All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK. DIABETES OBESITY & METABOLISM. 2023; 25(1). DOI:10.1111/dom.14856. PMID:36056765. IF:5,400 (Q1/2D). Document type: Article.

-López A, Padro T, Villaplana VD, Muñoz N, Pérez A, Vilahur G, Badimon L. Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects. Nutrients. 2023; 15(24):5084. DOI:10.3390/nu15245084. PMID:38140343. IF:4,800 (Q1/2D). Document type: Article.

-Mangas N, Mateu M, Martinez MJ, Lopez A, Pujol I, Martinez C, Corcoy R. Hybrid closed-loop systems can help patients with extreme fear of hypoglycemia or hyperglycemia. Hormones-International Journal of Endocrinology and Metabolism. 2023; 22(3). DOI:10.1007/s42000-023-00451-9. PMID:37198528. IF:2,400 (Q3/7D). Document type: Article.

-Masson W, Barbagelata L, Godinez E, Genua I, Nogueira JP. Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review. Indian Journal Of Gastroenterology. 2023; DOI:10.1007/s12664-023-01457-2. PMID:38036914. IF:2,000 (Q3/7D). Document type: Review.

-Mathiesen ER, Alibegovic AC, Corcoy R, Dunne F, Feig DS, Hod M, Jia T, Kalyanam B, Kar S, Kautzky A, Marchesini C, Rea RD, Damm P, EXPECT G. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial. Lancet Diabetes & Endocrinology. 2023; 11(2). DOI:10.1016/S2213-8587(22)00307-2. PMID:36623517. IF:44,000 (Q1/1D). Document type: Article.

-Mauricio D, Gratacòs M, Franch J. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves. Cardiovascular Diabetology. 2023; 22(1):314. DOI:10.1186/s12933-023-02056-3. PMID:37968679. IF:8,500 (Q1/1D). Document type: Review.

-Mauricio D, Vlacho B, Ortega E, Cos X, Mata M, Real J, Fernandez B, Franch J. Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves. Primary Care Diabetes. 2023; 17(1). DOI:10.1016/j.pcd.2022.12.002. PMID:36528549. IF:2,600 (Q1/3D). Document type: Article.

-Mendoza LC, Tashkova M, Corcoy R, Dornhorst A. Pregnancy induces longitudinal changes in urinary C-peptide creatinine ratio in women with type 1 diabetes. DIABETIC MEDICINE. 2023; 41(1):e15154. DOI:10.1111/dme.15154. PMID:37227744. IF:3,200 (Q2/5D). Document type: Article.

-Miñambres I, de Hollanda A, Vilarrasa N, Pellitero S, Rubio MA, Flores L, Caixàs A, Lobo S, Martinez JI, Acevedo B, Moizé V, Andreu A, Escalada J, S, S, S, A, S, S. Obesity and fertility. Position statement. Endocrinologia Diabetes y Nutricion. 2023; 70. DOI:10.1016/j.endinu.2022.10.002. IF:1,800 (Q3/8D). Document type: Article.

-Miñambres I, de Hollanda A, Vilarrasa N, Pellitero S, Rubio MA, Flores L, Caixàs A, Lobo S, Martinez JI, Acevedo B, Moizé V, Andreu A, Escalada J, S. Obesity and fertility. Position statement. Endocrinologia Diabetes y Nutricion. 2023; 70 Suppl 1. DOI:10.1016/j.endien.2023.03.003. PMID:36907798. IF:1,800 (Q3/8D). Document type: Article.

-Mollo A, Vlacho B, Gratacos M, Mata M, Rubinat E, Berenguera A, Real J, Puig R, Cos X, Franch J, Khunti K, Mauricio D, INTEGRA GRP. Impact of a multicomponent healthcare intervention on glycaemic control in subjects with poorly controlled type 2 diabetes: The INTEGRA study. DIABETES OBESITY & METABOLISM. 2023; 25(4). DOI:10.1111/dom.14951. PMID:36546592. IF:5,400 (Q1/2D). Document type: Article.

-Mollo A, Vlacho B, Gratacos M, Mata M, Rubinat E, Osso AB, Cos FX, Franch J, Khunti K, Mauricio D. A multicomponent health care intervention is associated with improved glycaemic control in subjects with poorly controlled type 2 diabetes compared with routine care: The INTEGRA study. DIABETES OBESITY & METABOLISM. 2023; 25(12). DOI:10.1111/dom.15250. PMID:37608473. IF:5,400 (Q1/2D). Document type: Article.

-Monroy G, Fernández C, Olmo R, Martínez MJ, DE Leiva A, Corcoy R. Breastfeeding is associated with a delayed decrease in postprandial maternal  glucose concentration. Minerva Endocrinology. 2023; 48(4). DOI:10.23736/S2724-6507.23.03962-3. PMID:37158811. IF:2,500 (Q3/7D). Document type: Article.

-Muller D, Freemantle N, Bonadonna RC, Mauquoi C, Bigot G, Bonnemaire M, Gourdy P, Mauricio D. Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database. Diabetes Therapy. 2023; 14(2). DOI:10.1007/s13300-022-01356-3. PMID:36596946. IF:2,800 (Q3/6D). Document type: Article.

-Munoz JP, Sanchez P, Diarte E, Zorzano A, Blanco F, Julve J. FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(8):7374. DOI:10.3390/ijms24087374. PMID:37108539. IF:4,900 (Q1/3D). Document type: Article.

-Navas M, Almendra R, Puertas L, Jimenez F, Julve J, Perez B, Consegal M, Kassan M, Martinez J, Rodriguez C, Galan M. Targeting mitochondrial stress with Szeto-Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stress. BRITISH JOURNAL OF PHARMACOLOGY. 2023; 180(17). DOI:10.1111/bph.16077. PMID:36964990. IF:6,800 (Q1/1D). Document type: Article.

-Nino J, Rojo MI, Martinez P, Rossell J, Ruiz AJ, Alonso N, Ramos B, Mauricio D, Julve J. NAD plus Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota. Nutrients. 2023; 15(13):2992. DOI:10.3390/nu15132992. PMID:37447318. IF:4,800 (Q1/2D). Document type: Review.

-Niño-Narvión J, Camacho M, Julve J. NAD+ Precursors: A Physiological Reboot? Nutrients. 2023; 15(20):4479. DOI: 10.3390/nu15204479. PMID: 37892554. IF:4,800 (Q1/2D). Document type: Editorial Material.

-Ortega E, Vlacho B, Treserres RP, Mata M, Altes A, Mauricio D, Franch J. Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia,  Spain. Journal of Clinical Lipidology. 2023; 17(6). DOI:10.1016/j.jacl.2023.09.002. PMID:37741728. IF:3,600 (Q2/3D). Document type: Article.

-Padro T, López A, Pérez A, Vilahur G, Badimon L. Dietary ?3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study. Nutrients. 2023; 15(16):3637. DOI:10.3390/nu15163637. PMID:37630826. IF:4,800 (Q1/2D). Document type: Article.

-Pedro J, Barrios V, Sánchez V, Tamargo J, Arrieta F, Gámez JM, Gimeno JA, Escobar C, Gómez JJ, Pérez A, en nombre S. Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología. Endocrinologia Diabetes y Nutricion. 2023; 70. DOI:10.1016/j.endinu.2022.03.004. IF:1,800 (Q3/8D). Document type: Article.

-Pedro J, Barrios V, Sánchez V, Tamargo J, Arrieta F, Gámez JM, Gimeno JA, Escobar C, Gómez JJ, Pérez A, Working Groups of Cardiovascular Pharmacotherapy of the Sociedad Española de Ca . Treatment of hypertriglyceridaemia with icosapent ethyl in patients with  high/very high cardiovascular risk. Consensus document of the Sociedad Española  de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de  Diabetes [Spanish Diabetes Society]. Endocrinologia Diabetes y Nutricion. 2023; 70(Suppl.1). DOI:10.1016/j.endien.2022.11.009. PMID:36402735. IF:1,800 (Q3/8D). Document type: Article.

-Pennells L, Kaptoge S, Ostergaard HB, Read SH, Carinci F, Franch J, Petitjean C, Taylor O, Hageman SHJ, Xu Z, Shi FC, Spackman S, Gualdi S, Holman N, Costa R, Bonnet F, Brenner H, Kiechl S, Lawlor DA, Potier L, Schottker B, Sofat R, Volzke H, Willeit J, Baltane Z, Fava S, Janos S, Lavens A, Pildava S, Poljicanin T, Pristas I, Rossing P, Sascha R, Scheidt C, Stotl I, Tibor G, Urbancic V, Vanherwegen AS, Vistisen D, Du Y, Walker MR, Willeit P, Ference B, De Bacquer D, Halle M, Huculeci R, McEvoy JW, Timmis A, Vardas P, Dorresteijn J, Graham I, Wood A, Eliasson B, Herrington W, Danesh J, Mauricio D, Benedetti MM, Sattar N, Visseren FLJ, Wild S, Di E, Balkau B, Fumeron F, Stocker H, Holleczek B, Schipf S, Schmidt CO, Doerr M, Tilg H, Leitner C, Notdurfter M, Taylor J, Dale C, Prieto D, Gillum RF, Buble T, Ivanko P, Carstensen B, Heidemann C, Gall T, Sandor J, Lepiksone J, Magri CJ, Azzopardi J, Real J, Vlacho B, Mata M, SCORE2 GRP, ESC Cardiovasc Risk C, ERFC I, SIDIAP I. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. EUROPEAN HEART JOURNAL. 2023; 44(28). DOI:10.1093/eurheartj/ehad260. PMID:37247330. IF:38,100 (Q1/1D). Document type: Article.

-Pérez A, Redondo J, Romera I, Lizán L, Santos MRD, Díaz S, Orozco D. Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review. Diabetes Therapy. 2023; DOI:10.1007/s13300-023-01503-4. PMID:37989829. IF:2,800 (Q3/6D). Document type: Review.

-Reis A, Rocha S, Dias IH, Costa R, Soares R, Sánchez JL, Perez A, de Freitas V. Type 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteins. Redox Biology. 2023; 59:102572. DOI:10.1016/j.redox.2022.102572. PMID:36516720. IF:10,700 (Q1/1D). Document type: Article.

-Revilla G, Al Qtaish N, Caruana P, Sainz M, Lopez T, Rodriguez F, Paez V, Li CD, Vallverdú NF, Edwards M, Moral A, Pérez JI, Escolà JC, Pedraz JL, Gallego I, Corcoy R, Céspedes MV, Puras G, Mato E. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior. Biomolecules. 2023; 13(11):1647. DOI:10.3390/biom13111647. PMID:38002329. IF:4,800 (Q1/3D). Document type: Article.

-Revilla G, Ruiz L, Vallverdu NF, Santamaria P, Moral A, Perez JI, Li CD, Fuste V, Lerma E, Corcoy R, Pitoia F, Escola JC, Mato E. Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13):11153. DOI:10.3390/ijms241311153. PMID:37446330. IF:4,900 (Q1/3D). Document type: Article.

-Rodriguez R, Granado M, de Oca A, Julian MT, Domingo M, Codina P, Santiago E, Cediel G, Julve J, Rossell J, Masana L, Mauricio D, Lupon J, Bayes A, Alonso N. Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus. Antioxidants. 2023; 12(3):645. DOI:10.3390/antiox12030645. PMID:36978893. IF:6,000 (Q1/2D). Document type: Article.

-Rojo MI, Bermúdez M, Castro E, Farràs C, Torres G, Pamplona R, Lecube A, Valdivielso JM, Fernández E, Julve J, Castelblanco E, Franch J, Alonso N, Granado M, Mauricio D, Miquel E, Ortega M, Barbé F, González J, Barril S, Sánchez M, Portero M, Jové M, Hernández M, Rius F, Godoy P, Alonso MM, ILERVAS C. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort. ATHEROSCLEROSIS. 2023; 380:117191. DOI:10.1016/j.atherosclerosis.2023.117191. PMID:37586219. IF:4,900 (Q1/2D). Document type: Article.

-Rossell J, Rojo MI, Julve J, Mauricio D. The Bittersweet Beat: Diabetes Complications. Journal of Clinical Medicine. 2023; 12(12):4018. DOI:10.3390/jcm12124018. PMID:37373711. IF:3,000 (Q1/2D). Document type: Editorial Material.

-Roth L, Dogan S, Tuna BG, Aranyi T, Benitez S, Borrell M, Bozaykut P, De Meyer GRY, Duca L, Durmus N, Fonseca D, Fraenkel E, Gillery P, Giudici A, Jaisson S, Johansson M, Julve J, Lucas AK, Martinet W, Maurice P, McDonnell BJ, Ozbek EN, Pucci G, Pugh C, Rochfort KD, Roks A, Rotllan N, Shadiow J, Sohrabi Y, Spronck B, Szeri F, Terentes D, Aydin ET, Tura O, Ucar E, Yetik G. Pharmacological modulation of vascular ageing: A review from VascAgeNet. AGEING RESEARCH REVIEWS. 2023; 92:102122. DOI:10.1016/j.arr.2023.102122. PMID:37956927. IF:12,500 (Q1/1D). Document type: Review.

-Sánchez E, Sánchez M, López C, Bermúdez M, Valdivielso JM, Farras C, Pamplona R, Torres G, Mauricio D, Castro E, Fernández E, Lecube A. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project. Nutrients. 2023; 15(1):203. DOI:10.3390/nu15010203. PMID:36615860. IF:4,800 (Q1/2D). Document type: Article.

-Sanjurjo L, Castelblanco E, Julve J, Villalmanzo N, Tellez E, Ramirez A, Alonso N, Mauricio D, Sarrias MR. Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14. Antioxidants. 2023; 12(5):1083. DOI:10.3390/antiox12051083. PMID:37237950. IF:6,000 (Q1/2D). Document type: Article.

-Simo R, Franch J, Vlacho B, Real J, Amado E, Flores J, Mata M, Ortega E, Rigla M, Valles J-A, Hernandez C, Mauricio D. Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes. DIABETES CARE. 2023; 46(9). DOI:10.2337/dc22-2521. PMID:37428631. IF:14,800 (Q1/1D). Document type: Article.

-Sprankel L, Vizarraga D, Martín J, Manger S, Meier J, Marcos M, Julve J, Rotllan N, Scheffer MP, Escolà JC, Langer JD, Piñol J, Fita I, Frangakis AS. Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas. NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2023; 30(3). DOI:10.1038/s41594-023-00922-y. PMID:36782049. IF:12,500 (Q1/1D). Document type: Article.

-Tejera C, Chico A, Azriel S, Lardies B, Gomez F, Area S. Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN). Diabetes Therapy. 2023; 14(7). DOI:10.1007/s13300-023-01417-1. PMID:37188930. IF:2,800 (Q3/6D). Document type: Article.

-Tobias DK, Merino J, Ahmad A, Aiken C, Benham JL, Bodhini D, Clark AL, Colclough K, Corcoy R, Cromer SJ, Duan D, Felton JL, Francis EC, Gillard P, Gingras V, Gaillard R, Haider E, Hughes A, Ikle JM, Jacobsen LM, Kahkoska AR, Kettunen JLT, Kreienkamp RJ, Lim LL, Männistö J, Massey R, Mclennan NM, Miller RG, Morieri ML, Most J, Naylor RN, Ozkan B, Patel KA, Pilla SJ, Prystupa K, Raghavan S, Rooney MR, Schön M, Semnani Z, Sevilla M, Svalastoga P, Takele WW, Tam CH, Thuesen A, Tosur M, Wallace AS, Wang CC, Wong JJ, Yamamoto JM, Young K, Amouyal C, Andersen MK, Bonham MP, Chen M, Cheng F, Chikowore T, Chivers SC, Clemmensen C, Dabelea D, Dawed AY, Deutsch AJ, Dickens LT, DiMeglio LA, Dudenhöffer M, Evans C, Fernández MM, Fitipaldi H, Fitzpatrick SL, Gitelman SE, Goodarzi MO, Grieger JA, Guasch M, Habibi N, Hansen T, Huang C, Harris A, Ismail HM, Hoag B, Johnson RK, Jones AG, Koivula RW, Leong A, Leung GKW, Libman IM, Liu K, Long SA, Lowe WLJR, Morton RW, Motala AA, Onengut S, Pankow JS, Pathirana M, Pazmino S, Perez D, Petrie JR, Powe CE, Quinteros A, Jain R, Ray D, Ried M, Saeed Z, Santhakumar V, Kanbour S, Sarkar S, Monaco GSF, Scholtens DM, Selvin E, Sheu WH, Speake C, Stanislawski MA, Steenackers N, Steck AK, Stefan N, STØYJ, Taylor R, Tye SC, Ukke GG, Urazbayeva M, Van der Schueren B, Vatier C, Wentworth JM, Hannah W, White SL, Yu G, Zhang Y, Zhou SJ, Beltrand J, Polak M, Aukrust I, de Franco E, Flanagan SE, Maloney KA, McGovern A, Molnes J, Nakabuye M, Njølstad PR, Pomares H, Provenzano M, Saint C, Zhang C, Zhu Y, Auh S, de Souza R, Fawcett AJ, Gruber C, Mekonnen EG, Mixter E, Sherifali D, Eckel RH, Nolan JJ, Philipson LH, Brown RJ, Billings LK, Boyle K, Costacou T, Dennis JM, Florez JC, Gloyn AL, Gomez MF, Gottlieb PA, Greeley S, Griffin K, Hattersley AT, Hirsch IB, Hivert MF, Hood KK, Josefson JL, Kwak SH, Laffel LM, Lim SS, Loos RJF, Ma RCW, Mathieu C, Mathioudakis N, Meigs JB, Misra S, Mohan V, Murphy R, Oram R, Owen KR, Ozanne SE, Pearson ER, Perng W, Pollin TI, Pop R, Pratley RE, Redman LM, Redondo MJ, Reynolds RM, Semple RK, Sherr JL, Sims EK, Sweeting A, Tuomi T, Udler MS, Vesco KK, Vilsbøll T, Wagner R, Rich SS, Franks PW. Second international consensus report on gaps and opportunities for the clinical  translation of precision diabetes medicine. NATURE MEDICINE. 2023; 29(10). DOI:10.1038/s41591-023-02502-5. PMID:37794253. IF:58,700 (Q1/1D). Document type: Article.

-Torres JK, Niño J, Martinez P, Diarte EMG, Méndez KA, del Olmo TV, Rotllan N, Julián MT, Alonso N, Mauricio D, Camacho M, Muñoz JP, Rossell J, Julve J. Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms. Nutrients. 2023; 15(14):3083. DOI:10.3390/nu15143083. PMID:37513501. IF:4,800 (Q1/2D). Document type: Article.

-Velilla TA, Guijarro C, Ruiz RC, Pinero MR, Marcos JFV, Perez AP, Lopez M, Lopez AM, Donaire J, Obaya JC, Guerra LC, Carratala VP, Cabello IE, Lazo MS, Rodrigo MMC, Prieto JMM, Doblas JJG, Soto AB, Multidisciplinar GRP. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? Clinica E Investigacion En Arteriosclerosis. 2023; 35(2). DOI:10.1016/j.arteri.2022.10.002. PMID:36925360. IF:1,900 (Q3/6D). Document type: Article.

-Velilla TA, Guijarro C, Ruiz RC, Piñero MR, Marcos JF, Pérez AP, López A, López AM, Donaire J, Obaya JC, Guerra LC, Carratalá VP, Cabello IE, Lazo MS, Rodrigo MMC, Prieto JMM, Doblas JJG, Soto AB, Multidisciplinary F. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2023; 4(2). DOI:10.1515/almed-2023-0047. PMID:38075943. IF:1,100 (Q3/8D). Document type: Article.

-Velilla TA, Guijarro C, Ruiz RC, Piñero MR, Marcos JFV, Pérez AP, López MAB, López AM, Donaire JAG, Obaya JC, Guerra LC, Carratalá VP, Cabello IE, Lazo MS, Rodrigo MMC, Prieto JMM, Doblas JJG, Soto AB, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include? Neurology Perspectives. 2023; 3(2):100126. DOI:10.1016/j.neurop.2023.100126. Document type: Article.

-Vlacho B, Mata M, Fernandez B, Liebana LR, Barrot J, Franch J. Adherence to the therapeutic guidelines recommendations among the people with type 2 diabetes mellitus and obesity, frailty, or recent diagnosis, attended in primary health care centers in Spain: A cross-sectional study. Frontiers in Medicine. 2023; 10:1138956. DOI:10.3389/fmed.2023.1138956. PMID:37035300. IF:3,100 (Q1/2D). Document type: Article.

-Xie X, Liu J, García A, Chico A, Mateu M, Amigó J, Adelantado JM, Corcoy R. Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus. ACTA DIABETOLOGICA. 2023; 60(5). DOI:10.1007/s00592-023-02031-0. PMID:36707439. IF:3,100 (Q2/5D). Document type: Article.

-Xie X, Liu J, García A, Chico A, Mateu M, Amigó J, Adelantado JM, Corcoy R. Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics. Hormones-International Journal of Endocrinology and Metabolism. 2023; DOI:10.1007/s42000-023-00497-9. PMID:37845472. IF:2,400 (Q3/7D). Document type: Article.

(JIF 2022)

• Acosta P, Leopold B, Simmons D, Devlieger R, Galjaard S, Corcoy R, Adelantado JM, Dunne F, Harreiter J, Kautzky A, Damm P, Mathiesen ER, Jensen DM, Andersen LL, Tanvig M, Lapolla A, Dalfra MG, Bertolotto A, Wender E, Zawiejska A, Hill DJ, Snoek FJ, Jelsma JGM, Desoye G, van MNM. The unexplored role of sedentary time and physical activity in glucose and lipid metabolism-related placental mRNAs in pregnant women who are obese: the DALI lifestyle randomised controlled trial. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2022; 129(5). DOI:10.1111/1471-0528.16945. PMID:34559946. IF:5,8 (Q1/2D). Document type: Article.
• Amigo J, Corcoy R. Type 1 diabetes and pregnancy: An update on glucose monitoring and insulin treatment. Endocrinologia Diabetes y Nutricion. 2022; 69(6). DOI:10.1016/j.endien.2022.06.008. PMID:35787359. IF:1,9 (Q4/9D). Document type: Review.
• Antonio V, Cayla JA, Real J, Moreno A, Orcau A, Mauricio D, Mata M, Julve J, Mendez EN, Treserra RP, Millet JP, Garcia JLD, Vlacho B, Franch J. Glycemic control and the risk of tuberculosis in patients with diabetes: A cohort study in a Mediterranean city. Frontiers in Public Health. 2022; 10:1017024. DOI:10.3389/fpubh.2022.1017024. PMID:36466495. IF:5,2 (Q1/3D). Document type: Article.
• Antonio V, Franch J, Moreno A, Real J, Orcau A, Mauricio D, Mata M, Julve J, Mendez EN, Treserra RP, de la Puente JB, Millet JP, Garcia JLD, Vlacho B, Cayla JA. Subjects With Diabetes Mellitus Are at Increased Risk for Developing Tuberculosis: A Cohort Study in an Inner-City District of Barcelona (Spain). Frontiers in Public Health. 2022; 10:789952. DOI:10.3389/fpubh.2022.789952. PMID:35677764. IF:5,2 (Q1/3D). Document type: Article.
• Aulinas A, Stantonyonge N, Garcia A, Adelantado JM, Medina C, Espinos JJ, Lopez E, Webb SM, Corcoy R. Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome. Pituitary. 2022; 25(2). DOI:10.1007/s11102-021-01196-7. PMID:34846622. IF:3,8 (Q2/5D). Document type: Article.
• Bahrami J, Tomlinson G, Murphy HR, Feig DS, CONCEPTT GRP [Corcoy R, Chico AI]. Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes. DIABETIC MEDICINE. 2022; 39(5):e14789. DOI:10.1111/dme.14789. PMID:35030277. IF:3,5 (Q3/6D). Document type: Article.
• Barrios V, Beato P, Brotons C, Campuzano R, Merino JF, Mostaza JM, Plana N, Rubio JA, Comellas M, CREVASP GRP [Pérez-Pérez A]. Comprehensive management of risk factors in peripheral vascular disease. Expert consensus. REVISTA CLINICA ESPANOLA. 2022; 222(2). DOI:10.1016/j.rceng.2020.11.011. PMID:34217671. IF:2,9 (Q2/5D). Document type: Article.
• Barrot J, Real J, Vlacho B, Romero P, Simo R, Mauricio D, Mata M, Castelblanco E, Mundet X, Franch J. Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes. Frontiers in Medicine. 2022; 9:945245. DOI:10.3389/fmed.2022.945245. PMID:36052329. IF:3,9 (Q2/4D). Document type: Article.
• Bermudez M, Marti M, Castro E, Bretones MD, Farras C, Torres G, Pamplona R, Lecube A, Mauricio D, Valdivielso JM, Fernandez E, ILERVAS C. Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study. Frontiers in Cardiovascular Medicine. 2022; 9:895917. DOI:10.3389/fcvm.2022.895917. PMID:35928938. IF:3,6 (Q2/5D). Document type: Article.
• Blanco F, Rotllan N, Canyelles M, Mauricio D, Escola JC, Julve J. NAD plus -Increasing Strategies to Improve Cardiometabolic Health?. Frontiers in Endocrinology. 2022; 12:815565. DOI:10.3389/fendo.2021.815565. PMID:35173682. IF:5,2 (Q1/3D). Document type: Review.
• Brotons C, Camafort M, Castellanos MD, Clara A, Cortes O, Rodriguez AD, Elosua R, Gorostidi M, Hernandez AM, Herranz M, Justo S, Lahoz C, Nino P, Pallares V, Pedro J, Pérez-Pérez A, Royo MA, Santamaria R, Tresserras R, Zamora A, Zuza I, Armario P. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. Clinica E Investigacion En Arteriosclerosis. 2022; 34(4). DOI:10.1016/j.arteri.2022.03.003. PMID:35906022. Document type: Article.
• Brotons C, Camafort M, Castellanos MD, Clara A, Cortes O, Rodriguez AD, Elosua R, Gorostidi M, Hernandez AM, Herranz M, Justo S, Lahoz C, Nino P, Pallares V, Pedro J, Pérez-Pérez A, Royo MA, Santamaria R, Tresserras R, Zamora A, Zuza I, Armario P. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. Hipertension Y Riesgo Vascular. 2022; 39(2). DOI:10.1016/j.hipert.2022.02.003. PMID:35331672. Document type: Article/Practice guideline.
• Brotons C, Camafort M, Castellanos MD, Clara A, Cortes O, Rodriguez AD, Elosua R, Gorostidi M, Hernandez AM, Herranz M, Justo S, Lahoz C, Nino P, Pallares V, Pedro J, Pérez-Pérez A, Royo MA, Santamaria R, Tresserras R, Zamora A, Zuza I, Armario P. Statement of the Spanish interdisciplinary vascular prevention committee on the updated European guidelines on cardiovascular disease prevention 2021. 2022; 74(5). DOI:10.20960/angiologia.00411. Document type: Article.
• Bundo M, Vlacho B, Llussa J, Puig R, Mata M, Cos X, Jude EB, Franch J, Mauricio D. Prevalence and risk factors of diabetic foot disease among the people with type 2 diabetes using real-world practice data from Catalonia during 2018. Frontiers in Endocrinology. 2022; 13:1024904. DOI:10.3389/fendo.2022.1024904. PMID:36353236. IF:5,2 (Q1/3D). Document type: Article.
• Canyelles M, Pérez-Pérez A, Junza A, Minambres I, Yanes O, Sarda H, Rotllan N, Julve J, Sanchez JL, Tondo M, Escola JC, Blanco F. Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese. Diagnostics. 2022; 12(11):2783. DOI:10.3390/diagnostics12112783. PMID:36428843. IF:3,6 (Q2/4D). Document type: Article.
• Casas JAV, Sambo M, López CL, Durán M, García JR-V, Santos RJ, Llanos M, Navarro E, Aller J, Pubul V, Guadalix S, Crespo G, González C, Zafón C, Navarro M, Santamaría J, Segura Á, Gajate P, Gómez M, Valdivia J, Puig M, Galofré JC, Castelo B, Villanueva MJ, Argüelles I, Orcajo L. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study. European Thyroid Journal. 2022; 11(5):e210111. DOI:10.1530/ETJ-21-0111. PMID:35900793. IF:4,7 (Q2/3D). Document type: Article.
• Castelblanco E, Granado M, Hernandez M, Pinyol M, Correig E, Julve J, Rojo MI, Alonso N, Avogaro A, Ortega E, Mauricio D. Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study. Frontiers in Cardiovascular Medicine. 2022; 9:945421. DOI:10.3389/fcvm.2022.945421. PMID:36407461. IF:3,6 (Q2/5D). Document type: Article.
• Castelblanco E, Hernandez M, Alonso N, Ribes A, Real J, Granado M, Rossell J, Rojo MI, Dusso AS, Julve J, Mauricio D. Association of alpha-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitus. Cardiovascular Diabetology. 2022; 21(1):207. DOI:10.1186/s12933-022-01640-3. PMID:36221075. IF:9,3 (Q1/2D). Document type: Article.
• Cebrian AM, Mata M, Franch J, Mauricio D, Orozco D, Consuegra L. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population. European Journal of Preventive Cardiology. 2022; 28(18):zwaa073. DOI:10.1093/eurjpc/zwaa073. PMID:33733654. IF:8,3 (Q1/2D). Document type: Letter.
• Cediel G, Teis A, Codina P, Julve J, Domingo M, Santiago E, Castelblanco E, Amigo N, Lupon J, Mauricio D, Alonso N, Bayes A. GlycA and GlycB as Inflammatory Markers in Chronic Heart Failure. AMERICAN JOURNAL OF CARDIOLOGY. 2022; 181. DOI:10.1016/j.amjcard.2022.07.019. PMID:36008162. IF:2,8 (Q3/6D). Document type: Article.
• Chico A, Corcoy R. Intensive Insulin Therapy (Basal-Bolus). AMERICAN JOURNAL OF THERAPEUTICS. 2022; 29(1). DOI:10.1097/MJT.0000000000001152. PMID:33031154. IF:4,2 (Q2/4D). Document type: Article.
• Corcoy R, Lucas A, Gomis R, Mauricio D, Wagner A, Jimenez A, Fajardo C, Ballesteros M, Gimeno JA, Zafon C. Our journal is 65 years-old: A look back at the past. Endocrinologia Diabetes y Nutricion. 2022; 69(4). DOI:10.1016/j.endinu.2019.07.006; DOI(English Edition):10.1016/j.endien.2019.07.008. PMID:35353684. IF:1,9 (Q4/9D). Document type: Article.
• Das A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Pall D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM, PROMINENT Investigators Grp. [Pérez-Pérez A]. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. NEW ENGLAND JOURNAL OF MEDICINE. 2022; 387(21). DOI:10.1056/NEJMoa2210645. PMID:36342113. IF:158,5 (Q1/1D). Document type: Article.
• Fernandez S, Ballester E, Gonzalo B, Codina C, Minambres I, Pérez-Pérez A, Gich I, Gonzalez S, Serrano C, Balague C. Is Sleeve Gastrectomy as Effective in Older Patients as in Younger Patients? A Comparative Analysis of Weight Loss, Related Comorbidities, and Medication Requirements. OBESITY SURGERY. 2022; 32(6). DOI:10.1007/s11695-022-05940-1. PMID:35411452. IF:2,9 (Q2/3D). Document type: Article.
• Franch J, Gatius JR, Mata M, Ortega E, Valles JA, Vlacho B, Mauricio D. Compliance with the DPP-4 inhibitors dose adjustment recommendations based on renal function in a population database. Endocrinologia Diabetes y Nutricion. 2022; 69(2). DOI:10.1016/j.endien.2022.02.011. PMID:35256063. IF:1,9 (Q4/9D). Document type: Article.
• Franch J, Granado M, Mata M, Ortega E, Vlacho B, Mauricio D. Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world. Primary Care Diabetes. 2022; 16(6). DOI:10.1016/j.pcd.2022.10.005. PMID:36336605. IF:2,9 (Q2/5D). Document type: Article.
• Franch J, Real J, Mata M, Ortega E, Valles JA, Vlacho B, Mauricio D. Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database. Endocrinologia Diabetes y Nutricion. 2022; 69(2). DOI:10.1016/j.endinu.2021.01.013. PMID:34088634. IF:1,9 (Q4/9D). Document type: Article.
• Garcia A, Balsells M, Bartha JL, Sola I, Corcoy R. Current evidence about better perinatal outcomes associated to one step approach in the diagnosis of gestational diabetes mellitus is not of high quality. Journal of Maternal-Fetal & Neonatal Medicine. 2022; 35(8). DOI:10.1080/14767058.2020.1759532. PMID:32345088. IF:1,8 (Q4/8D). Document type: Letter.
• Gargallo M, Escalada J, Chico A, Lecumberri E, Tejera C, Fernandez JC, Rozas P, Marco A, Gomez F, Lopez J. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN). Endocrinologia Diabetes y Nutricion. 2022; 69(9). DOI:10.1016/j.endinu.2021.06.005. PMID:34489216. IF:1,9 (Q4/9D). Document type: Article/Practice guideline.
• Genua I, Franch J, Navas E, Mata M, Giménez G, Vlacho B, Mauricio D, Goday A. Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia. Frontiers in Endocrinology. 2022; 13:1015614. DOI:10.3389/fendo.2022.1015614. PMID:36531459. IF:5,2 (Q1/3D). Document type: Article.
• Gimenez G, Vlacho B, Navas E, Mata M, Real J, Cos X, Franch J, Mauricio D. Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area. DIABETES RESEARCH AND CLINICAL PRACTICE. 2022; 191:110031. DOI:10.1016/j.diabres.2022.110031. PMID:35934173. IF:5,1 (Q2/3D). Document type: Article.
• Gomez F, Carrasco FJ, Pérez-Pérez A, Escalada J, Alvarez F, Miranda C, Mediavilla JJ, Gomez R. Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document «Treatment of type 2 diabetes mellitus in the elderly». REVISTA CLINICA ESPANOLA. 2022; 222(8). DOI:10.1016/j.rce.2022.03.004; DOI(English Edition):10.1016/j.rceng.2022.03.005. PMID:35753941. IF:2,9 (Q2/5D). Document type: Article/Practice guideline.
• Gourdy P, Bonadonna RC, Freemantle N, Mauricio D, Muller D, Bigot G, Mauquoi C, Ciocca A, Bonnemaire M. Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis. Diabetes Therapy. 2022; 13(1). DOI:10.1007/s13300-021-01179-8. PMID:34784005. IF:3,8 (Q2/5D). Document type: Article.
• Granado M, Sola I, Hernandez M, Rojo MI, Julve J, Mauricio D. Effectiveness of medical nutrition therapy in adolescents with type 1 diabetes: a systematic review. Nutrition & Diabetes. 2022; 12(1):24. DOI:10.1038/s41387-022-00201-7. PMID:35459205. IF:6,1 (Q1/2D). Document type: Review.
• Grinan R, Escola JC, Julve J, Benitez S, Rotllan N. Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(20):12452. DOI:10.3390/ijms232012452. PMID:36293305. IF:5,6 (Q1/3D). Document type: Review.
• Harreiter J, Mendoza LC, Simmons D, Desoye G, Devlieger R, Galjaard S, Damm P, Mathiesen ER, Jensen DM, Andersen LLT, Dunne F, Lapolla A, Dalfra MG, Bertolotto A, Wender E, Zawiejska A, Hill D, Jelsma JGM, Snoek FJ, Worda C, Bancher D, van MNM, Corcoy R, Kautzky A, DALI Core Investigator GRP. Vitamin D3 Supplementation in Overweight/Obese Pregnant Women: No Effects on the Maternal or Fetal Lipid Profile and Body Fat Distribution-A Secondary Analysis of the Multicentric, Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial (DALI). 2022; 14(18):3781. DOI:10.3390/nu14183781. PMID:36145157. IF:5,9 (Q1/2D). Document type: Article.
• Harris S, Ruan Y, Wild SH, Wargny M, Hadjadj S, Delasalle B, Saignes M, Ryder RE, Field BCT, Narendran P, Zaccardi F, Wilmot EG, Vlacho B, Llauradó G, Mauricio D, Nagi D, Patel D, Várnai KA, Davies J, Gourdy P, Cariou B, Rea R, Khunti K, for C, the ABCD COVID HM. Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2022; 16(5):102484. DOI:10.1016/j.dsx.2022.102484. PMID:35472685. Document type: Article.
• Hernandez M, Novoa Y, Faner R, Palou E, Esquerda A, Castelblanco E, Wagner AM, Mauricio D. Genetics: Is LADA just late onset type 1 diabetes?. Frontiers in Endocrinology. 2022; 13:916698. DOI:10.3389/fendo.2022.916698. PMID:36034444. IF:5,2 (Q1/3D). Document type: Article.
• Jayaraman S, Pérez-Pérez A, Minambres I, Sanchez JL, Gursky O. Heparin binding triggers human VLDL remodeling by circulating lipoprotein lipase: Relevance to VLDL functionality in health and disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. 2022; 1867(1):159064. DOI:10.1016/j.bbalip.2021.159064. PMID:34610468. IF:4,8 (Q1/2D). Document type: Article.
• Julve J, Rossell J, Correig E, Rojo MI, Amigo N, Hernandez M, Traveset A, Carbonell M, Alonso N, Mauricio D, Castelblanco E. Predictive Value of the Advanced Lipoprotein Profile and Glycated Proteins on Diabetic Retinopathy. 2022; 14(19):3932. DOI:10.3390/nu14193932. PMID:36235586. IF:5,9 (Q1/2D). Document type: Article.
• Lima RA, Desoye G, Simmons D, van MNM, Corcoy R, Adelantado JM, Jelsma JGM. Mediators of lifestyle intervention effects on neonatal adiposity: are we missing a piece of the puzzle?. PEDIATRIC RESEARCH. 2022; 91(3). DOI:10.1038/s41390-021-01450-5. PMID:33753890. IF:3,6 (Q1/2D). Document type: Article.
• Llaurado G, Vlacho B, Wargny M, Ruan Y, Franch J, Domingo P, Gourdy P, Saulnier PJ, Hadjadj S, Wild SH, Rea R, Cariou B, Khunti K, Mauricio D. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19). Cardiovascular Diabetology. 2022; 21(1):216. DOI:10.1186/s12933-022-01657-8. PMID:36261811. IF:9,3 (Q1/2D). Document type: Article.
• Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovascular Diabetology. 2022; 21(1):74. DOI:10.1186/s12933-022-01516-6. PMID:35568946. IF:9,3 (Q1/2D). Document type: Review.
• Magliano DJ, Chen L, Carstensen B, Gregg EW, Pavkov ME, Salim A, Andes LJ, Balicer R, Baviera M, Chan JCN, Cheng YLJ, Gardiner H, Gulseth HL, Gurevicius R, Ha KH, Jermendy G, Kim DJ, Kiss Z, Leventer M, Lin CY, Luk A, Ma S, Mata M, Mauricio D, Nichols GA, Pildava S, Porath A, Read SH, Robitaille C, Roncaglioni MC, Ruiz PLD, Wang KL, Wild SH, Yekutiel N, Shaw JE. Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data. Lancet Diabetes & Endocrinology. 2022; 10(2). DOI:10.1016/S2213-8587(21)00327-2. PMID:35026157. IF:44,5 (Q1/1D). Document type: Article.
• Manzini E, Vlacho B, Franch J, Escudero J, Genova A, Reixach E, Andres E, Pizarro I, Portero JL, Mauricio D, Perera A. Longitudinal deep learning clustering of Type 2 Diabetes Mellitus trajectories using routinely collected health records. JOURNAL OF BIOMEDICAL INFORMATICS. 2022; 135:104218. DOI:10.1016/j.jbi.2022.104218. PMID:36216232. IF:4,5 (Q2/4D). Document type: Article.
• Mata M, Mauricio D, Real J, Vlacho B, Romera L, Molist N, Cedenilla M, Franch J. Potential Risk of Overtreatment in Patients with Type 2 Diabetes Aged 75 Years or Older: Data from a Population Database in Catalonia, Spain. Journal of Clinical Medicine. 2022; 11(17):5134. DOI:10.3390/jcm11175134. PMID:36079064. IF:3,9 (Q2/4D). Document type: Article.
• Mata M, Vlacho B, Real J, Puig R, Bundo M, Franch J, Mauricio D. Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018. Frontiers in Endocrinology. 2022; 12:810757. DOI:10.3389/fendo.2021.810757. PMID:35082758. IF:5,2 (Q1/3D). Document type: Article.
• Mateu M, Asla Q, Chico A, Martinez MC, Martinez MJ, Lopez A, Pujol I, Corcoy R. Feasibility of maintaining near-normal glucose control in pregnant women with type 1 diabetes during COVID-19 lockdown. ACTA DIABETOLOGICA. 2022; 59(7). DOI:10.1007/s00592-022-01862-7. PMID:35230539. IF:3,8 (Q2/5D). Document type: Article.
• Mateu M, Moreno J, Mangas N, Genua I, Martínez MJ, López A, González C, Chico A. Evaluation of the usefulness of and satisfaction with the flash glucose monitoring system (FreeStyle Libre (R)) guide for use in patients with type 1 diabetes. Endocrinologia Diabetes y Nutricion. 2022; 69(5). DOI:10.1016/j.endinu.2021.04.008. PMID:34452877. IF:1,9 (Q4/9D). Document type: Article/Practice guideline.
• Mauricio D, Vlacho B, de la Puente JB, Mundet X, Real J, Kulisevsky J, Ortega E, Castelblanco E, Julve J, Franch J. Associations Between Diabetic Retinopathy and Parkinson’s Disease: Results From the Catalonian Primary Care Cohort Study. Frontiers in Medicine. 2022; 8:800973. DOI:10.3389/fmed.2021.800973. PMID:35118094. IF:3,9 (Q2/4D). Document type: Article.
• Meek CL, Oram RA, McDonald TJ, Feig DS, Hattersley AT, Murphy HR, CONCEPTT GRP [Corcoy R, Chico AI]. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834. DIABETES CARE. 2022; 45(2). DOI:10.2337/dci21-0054. PMID:35050370. IF:16,2 (Q1/1D). Document type: Letter.
• Mendoza LC, Harreiter J, Desoye G, Simmons D, Adelantado JM, Kautzky A, Zawiejska A, Wender E, Lapolla A, Dalfra MG, Bertolotto A, Devlieger R, Dunne F, Mathiesen ER, Damm P, Andersen LL, Jensen DM, Hill D, van MNM, Corcoy R. The Weak Relationship between Vitamin D Compounds and Glucose Homeostasis Measures in Pregnant Women with Obesity: An Exploratory Sub-Analysis of the DALI Study. Nutrients. 2022; 14(16):3256. DOI:10.3390/nu14163256. PMID:36014761. IF:5,9 (Q1/2D). Document type: Article.
• Miñambres I, Sarda H, Urgell E, Genua I, Ramos A, Fernandez S, Balague C, Sanchez JL, Bassas L, Pérez-Pérez A. Obesity Surgery Improves Hypogonadism and Sexual Function in Men without Effects in Sperm Quality. Journal of Clinical Medicine. 2022; 11(17):5126. DOI:10.3390/jcm11175126. PMID:36079056. IF:3,9 (Q2/4D). Document type: Article.
• Monroy G, Fernandez C, Caballe T, Altimira L, Corcoy R. Breastfeeding effect on glucose tolerance assessment in women with previous gestational diabetes mellitus: A randomized controlled trial. DIABETIC MEDICINE. 2022; 39(11):e14954. DOI:10.1111/dme.14954. PMID:36053958. IF:3,5 (Q3/6D). Document type: Article.
• Moreno J, Chico A, Martínez MA, Beato PI, Vidal M, Piedra M, Quirós C, Muñoz JR. Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Mellitus Patients: Results from the Spanish National Registry. Diabetes Technology & Therapeutics. 2022; 24(12). DOI:10.1089/dia.2022.0207. PMID:35947087. IF:5,4 (Q1/3D). Document type: Article.
• Orozco D, Brotons C, Banegas JR, Gil VF, Cebrián AM, Martín E, Jordá A, Vicuña J, Navarro J, [Pérez-Pérez A (collab)]. Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS. Atencion Primaria. 2022; 54(Suppl 1):102444. DOI:10.1016/j.aprim.2022.102444. PMID:36435583. IF:2,5 (Q3/6D). Document type: Article/Practice guideline.
• Orozco D, Merino JF, Pérez-Pérez A, Cebrian AM, Parraga I, Avila L, Rojo G, Pomares FJ, Alvarez F, Sanchez M, Gutierrez F, Ortega FJ, Mata M, Carretero E, Vilaseca JM, Quesada JA. Diabetes Does Not Increase the Risk of Hospitalization Due to COVID-19 in Patients Aged 50 Years or Older in Primary Care-APHOSDIAB-COVID-19 Multicenter Study. Journal of Clinical Medicine. 2022; 11(8):2092. DOI:10.3390/jcm11082092. PMID:35456185. IF:3,9 (Q2/4D). Document type: Article.
• Orozco D, Morales C, Artola S, Brotons C, Carrascosa S, González C, Baro Ó, Aliaga A, de Campos KF, Villarejo M, Hurtado C, Álvarez C, Gómez A, Cedenilla M, Fernández G. Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes: The DeMpower Multicenter Ambispective Study. Jmir Diabetes. 2022; 7(4):e40377. DOI:10.2196/40377. Document type: Article.
• Pérez-Pérez A, Ortega Martínez de Victoria E, Arrieta F, Caixàs A, Santos E, Fernández P, Martínez S, López JA, Suárez L, Urgeles JR, Gatell S, Tinahones F. First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO). Endocrinologia Diabetes y Nutricion. 2022; 69(7). DOI:10.1016/j.endinu.2021.07.009. PMID:35995680. IF:1,9 (Q4/9D). Document type: Article.
• Pérez-Pérez A, Julián MT, Pera G, Caballería L, Morillas R, Torán P, Expósito C, Franch J, Mauricio D, Alonso N. Dysglycemia in young women attenuates the protective effect against fatty liver disease. Frontiers in Endocrinology. 2022; 13:971864. DOI:10.3389/fendo.2022.971864. PMID:36479218. IF:5,2 (Q1/3D). Document type: Article.
• Puig C, Castelblanco E, Falguera M, Hernandez M, Soldevila B, Julian MT, Teis A, Julve J, Barranco M, Franch J, Puig M, Ortega E, Amigo N, Alonso N, Mauricio D. Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(1). DOI:10.1016/j.recesp.2021.02.013. PMID:33785266. IF:5,9 (Q1/3D). Document type: Article.
• Puig C, Julve J, Castelblanco E, Julian MT, Amigo N, Andersen HU, Ahluwalia TS, Rossing P, Mauricio D, Jensen MT, Alonso N. The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. Cardiovascular Diabetology. 2022; 21(1):257. DOI:10.1186/s12933-022-01652-z. PMID:36434633. IF:9,3 (Q1/2D). Document type: Article.
• Puig Piña R. Trauma. Chapter 8: Tratamiento Médico Nutricional en Situaciones Específicas. In: BDB creatividad aplicada. 2022. ISBN:978-84-125642-2-8. DL:M-20702-2022. Document type: Book chapter.
• Ramirez A, Franch J, Real J, Gratacos M, Mauricio D. Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database. Journal of Clinical Medicine. 2022; 11(8):2196. DOI:10.3390/jcm11082196. PMID:35456292. IF:3,9 (Q2/4D). Document type: Article.
• Ramon J, Llaurado G, Guerri R, Climent E, Ballesta S, Benaiges D, Lopez I, Navarro H, Fernandez N, Carrera MJ, Mauricio D, Flores JA, Chillaron JJ. Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality. DIABETES CARE. 2022; 45(1). DOI:10.2337/dc21-1321. PMID:34782352. IF:16,2 (Q1/1D). Document type: Article.
• Revilla G, Moral A, Fuste V, Lerma E, Julve J, Escolà JC, Mato E, Pérez JI, Corcoy R, Paez EV. The role of ATP-binding cassette transporter genes in the metastatic process of epithelial thyroid carcinoma with aggressive behavior. In: Unraveling The Complexities Of Metastasis: Transition From A Segmented View To A Conceptual Continuum. Elsevier. 2022. p. 265-275. DOI: 10.1016/B978-0-12-821789-4.00020-5. Document type: Book chapter.
• Ruiz PLD, Chen L, Morton JI, Salim A, Carstensen B, Gregg EW, Pavkov ME, Mata M, Mauricio D, Nichols GA, P, Read SH, Wild SH, Shaw JE, Magliano DJ. Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts. 2022; 65(6). DOI:10.1007/s00125-022-05659-9. PMID:35314870. IF:8,2 (Q1/1D). Document type: Article.
• Sanchez E, Kerkeni M, Hernandez M, Gavalda R, Rius F, Sauret A, Torres G, Bermudez M, Fernandez E, Castro E, Purroy F, Mauricio D, Farras C, Buti M, Godoy P, Pamplona R, Lecube A, ILERVAS C. Weak Association between Skin Autofluorescence Levels and Prediabetes with an ILERVAS Cross-Sectional Study. 2022; 14(5):1102. DOI:10.3390/nu14051102. PMID:35268075. IF:5,9 (Q1/2D). Document type: Article.
• Sanchez E, Sapina E, Gavalda R, Barbe F, Torres G, Sauret A, Dalmases M, Lopez C, Gutierrez L, Bermudez M, Fernandez E, Purroy F, Castro E, Farras C, Pamplona R, Mauricio D, Hernandez C, Simo R, Lecube A. Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing. Journal of Clinical Medicine. 2022; 11(5):1413. DOI:10.3390/jcm11051413. PMID:35268504. IF:3,9 (Q2/4D). Document type: Article.
• Teis A, Castelblanco E, Cediel G, Amigó N, Julve J, Ribalta J, Guardiola M, Franch J, Bermúdez M, Codina P, Lupón J, Mauricio D, Alonso N, Bayés A. (1)H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11). DOI:10.1016/j.rec.2021.09.008. PMID:34716123. IF:5,9 (Q1/3D). Document type: Article.
• Teis A, Castelblanco E, Cediel G, Amigó N, Julve J, Ribalta J, Guardiola M, Franch J, Bermúdez M, Codina P, Lupón J, Mauricio D, Alonso N, Bayés A. Perfil lipoproteico por espectroscopia nuclear magnética en pacientes con insuficiencia cardiaca crónica comparado con controles emparejados. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11). DOI:10.1016/j.recesp.2021.09.007. IF:5,9 (Q1/3D). Document type: Article.
• Tomic D, Morton JI, Chen L, Salim A, Gregg EW, Pavkov ME, Arffman M, Balicer R, Baviera M, Boersma E, Brinks R, Carstensen B, Chan JCN, Cheng YJ, Fosse S, Fuentes S, Gardiner H, Gulseth HL, Gurevicius R, Ha KH, Hoyer A, Jermendy G, Kautzky A, Keskimäki I, Kim DJ, Kiss Z, Klimek P, Leventer M, Lin C-Y, Lopez P, Luk AOY, Ma S, Mata M, Mauricio D, McGurnaghan S, Imamura T, Paul SK, Peeters A, Pildava S, Porath A, Robitaille C, Roncaglioni MC, Sugiyama T, Wang K-L, Wild SH, Yekutiel N, Shaw JE, Magliano DJ. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet Diabetes & Endocrinology. 2022; 10(11). DOI:10.1016/S2213-8587(22)00252-2. PMID:36183736. IF:44,5 (Q1/1D). Document type: Article.
• Van Poppel MNM, Corcoy R, Hill D, Simmons D, Mendizabal L, Zulueta M, Simon L, Desoye G, Perez J, Kautzky A, Harreiter J, Damm P, Mathiesen E, Jensen DM, Andersen LLT, Dunne F, Lapolla A, Dalfra MG, Bertolotto A, van M, Jelsma JGM, Snoek FJ, Galjaard S, Wender E, Zawiejska A, Devlieger R, DALI Core Investigator GRP. Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial. AMERICAN JOURNAL OF CLINICAL NUTRITION. 2022; 115(2). DOI:10.1093/ajcn/nqab347. PMID:34669935. IF:7,1 (Q1/1D). Document type: Article.
• Vlacho B, Simarro FL, Mata M, Miravet S, Escribano J, Asensio D, Cortes X, Franch J. Adherence to antidiabetic treatment among patients managed in primary care centres in Spain: the INTENSE study. Primary Care Diabetes. 2022; 16(6). DOI:10.1016/j.pcd.2022.10.004. PMID:36335018. IF:2,9 (Q2/5D). Document type: Article.
• Zafaranieh S, Dieberger AM, Leopold B, Huppertz B, Granitzer S, Hengstschlager M, Gundacker C, Desoye G, van MNM, DALI Core Investigator GRP [Corcoy R]. Physical Activity and Sedentary Time in Pregnancy: An Exploratory Study on Oxidative Stress Markers in the Placenta of Women with Obesity. 2022; 10(5):1069. DOI:10.3390/biomedicines10051069. PMID:35625806. IF:4,7 (Q1/3D). Document type: Article.

• Abolbaghaei A, Langlois MA, Murphy HR, Feig DS, Burger D, Corcoy R, CONCEPTT GRP. Circulating extracellular vesicles during pregnancy in women with type 1 diabetes: a secondary analysis of the CONCEPTT trial. Biomarker Research. 2021; 9(1):67. DOI:10.1186/s40364-021-00322-8. PMID:34488911. IF:6,148 (Q1/D3).
• Arroyo JA, Julve J, Vlacho B, Corcoy R, Ponte P, Roman E, Navas E, Llaurado G, Franch J, Domingo P, Mauricio D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Frontiers in Public Health. 2021; 9:758347. DOI:10.3389/fpubh.2021.758347. PMID:34631653. IF:6,461.
• Bacon S, Burger D, Tailor M, Sanchez JJ, Tomlinson G, Murphy HR, Feig DS, Corcoy R, CONCEPTT GRP. Can placental growth factors explain birthweight variation in offspring of women with type 1 diabetes?. DIABETOLOGIA. 2021; 64(7). DOI:10.1007/s00125-021-05438-y. PMID:33839801. IF:10,460.
• Ballesteros Pomar MD, Vilarrasa García N, Rubio Herrera MÁ, Barahona MJ, Bueno M, Caixàs A, Calañas Continente A, Ciudin A, Cordido F, de Hollanda A, Diaz MJ, Flores L, García Luna PP, García Pérez-Sevillano F, Goday A, Lecube A, López Gómez JJ, Miñambres I, Morales Gorria MJ, Morinigo R, Nicolau J, Pellitero S, Salvador J, Valdés S, Bretón Lesmes I. The SEEN comprehensive clinical survey of adult obesity: Executive summary. Endocrinologia Diabetes y Nutricion. 2021;68(2):130-136. English, Spanish. DOI:10.1016/j.endinu.2020.05.003. PMID: 32933882. IF:1,833.
• Barranco M, Sola P, Picart S, Kanaan S, Fonollosa J, Perera A. mWISE: An Algorithm for Context-Based Annotation of Liquid Chromatography-Mass Spectrometry Features through Diffusion in Graphs. ANALYTICAL CHEMISTRY. 2021; 93(31). DOI:10.1021/acs.analchem.1c00238. PMID:34320315. IF:8,008.
• Battelino T, Mauricio D. Randomised Controlled Trials in Diabetes Research: A Pathway to Interpreting Published Results. Diabetes Therapy. 2021; 12(10). DOI:10.1007/s13300-021-01143-6. PMID:34455574. IF:3,595.
• Bellido V, Perez A. COVID-19 and Diabetes. Journal of Clinical Medicine. 2021; 10(22):5341. DOI:10.3390/jcm10225341. PMID:34830623. IF:4,964.
• Bellido V, Pérez A. Inpatient Hyperglycemia Management and COVID-19. Diabetes Therapy. 2021;12(1):121-132. DOI:10.1007/s13300-020-00966-z. PMID: 33278017. IF:3,595.
• Bermudez M, Perpinan H, Amigo N, Castro E, Alonso N, Mauricio D, Fernandez E, Valdivielso JM. Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients. Clinical Kidney Journal. 2021; 14(12). DOI:10.1093/ckj/sfab113. PMID:34950470. IF:5,860.
• Bermúdez-López M, Martínez-Alonso M, Castro-Boqué E, Betriu À, Cambray S, Farràs C, Barbé F, Pamplona R, Lecube A, Mauricio D, Purroy F, Valdivielso JM, Fernández E; ILERVAS project collaborators. Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study. REVISTA ESPANOLA DE CARDIOLOGIA. 2021;74(12):1042-1053. English, Spanish. DOI:10.1016/j.rec.2020.09.015. PMID: 33162389. IF:6,975.
• Bonadonna RC, Mauricio D, Muller D, Freemantle N, Bigot G, Mauquoi C, Ciocca A, Bonnemaire M, Gourdy P. Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis. Diabetes Therapy. 2021; 12(4). DOI:10.1007/s13300-021-01030-0. PMID:33650085. IF:3,595.
• Bonaterra A, Fernandez S, Rivas A, Puig N, Benitez S, Pancorbo O, Rodriguez D, Pujadas F, Freijo MD, Tur S, Martinez M, Portela PC, Vera R, Lebrato L, Arenillas JF, Perez S, Montaner J, Sanchez JL, Hernandez M. Comparison of Plasma Lipoprotein Composition and Function in Cerebral Amyloid Angiopathy and Alzheimer’s Disease. Biomedicines. 2021; 9(1):72. DOI:10.3390/biomedicines9010072. PMID:33445800. IF:4,757.
• Bundo M, Llussa J, Serra M, de la Iglesia PP, Gimbert RM, Real J, Vlacho B, Mata M, Cos X, Franch J, Mauricio D. Incidence and characteristics of diabetic foot ulcers in subjects with type 2 diabetes in Catalonian primary care centres: An observational multicentre study. Primary Care Diabetes. 2021; 15(6). DOI:10.1016/j.pcd.2021.08.002. PMID:34419365. IF:2,567.
• Castelblanco E, Hernandez M, Ortega E, Amigo N, Real J, Granado M, Minambres I, Lopez C, Lecube A, Bermudez M, Alonso N, Julve J, Mauricio D. Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2021; 182:109145. DOI:10.1016/j.diabres.2021.109145. PMID:34785302. IF:8,180.
• Castelblanco E, Sarrias MR, Betriu A, Soldevila B, Barranco M, Franch J, Valdivielso JM, Bermudez M, Groop PH, Fernandez E, Alonso N, Mauricio D. Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease. Aging-US. 2021; 13(19). DOI:10.18632/aging.203615. PMID:34629330. IF:5,955.
• Chiva G, Pena E, Cubedo J, Garcia M, Pane A, Gil PA, Perez A, Ortega E, Padro T, Badimon L. Molecular mapping of platelet hyperreactivity in diabetes: the stress proteins complex HSPA8/Hsp90/CSK2 alpha and platelet aggregation in diabetic and normal platelets. Translational Research. 2021; 235. DOI:10.1016/j.trsl.2021.04.003. PMID:33887528. IF:10,171.
• Colom C, Rull A, Sanchez JL, Perez A. Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk. Journal of Clinical Medicine. 2021; 10(8):1798. DOI:10.3390/jcm10081798. PMID:33924265. IF:4,964.
• Dieberger AM, Desoye G, Stolz E, Hill DJ, Corcoy R, Simmons D, Harreiter J, Kautzky-Willer A, Dunne F, Devlieger R, Wender-Ozegowska E, Zawiejska A, Lapolla A, Dalfra MG, Bertolotto A, Galjaard S, Adelantado JM, Jensen DM, Andersen LL, Tanvig M, Damm P, Mathiesen ER, Snoek FJ, Jelsma JGM, van Poppel MNM. Less sedentary time is associated with a more favourable glucose-insulin axis in obese pregnant women-a secondary analysis of the DALI study. INTERNATIONAL JOURNAL OF OBESITY. 2021;45(2):296-307. DOI:10.1038/s41366-020-0639-y. PMID: 32661292. IF:5,551.
• Doria M, Betriu A, Belart M, Rosado V, Hernandez M, Sarro F, Real J, Castelblanco E, Pacheco LR, Fernandez E, Franch J, Gratacos M, Mauricio D. High Incidence of Adverse Outcomes in Haemodialysis Patients with Diabetes with or without Diabetic Foot Syndrome: A 5-Year Observational Study in Lleida, Spain. Journal of Clinical Medicine. 2021; 10(7):1368. DOI:10.3390/jcm10071368. PMID:33810545. IF:4,964.
• Falguera M, Castelblanco E, Rojo MI, Vilanova MB, Real J, Alcubierre N, Miro N, Mollo A, Mata M, Franch J, Granado M, Mauricio D. Mediterranean Diet and Healthy Eating in Subjects with Prediabetes from the Mollerussa Prospective Observational Cohort Study. Nutrients. 2021; 13(1):252. DOI:10.3390/nu13010252. PMID:33467197. IF:6,706.
• Fuster VP, Perez AP, Gomez JC, Pedragos AC, Gomez R, Perez P. Executive summary: Updates to the dietary treatment of prediabetes and type 2 diabetes mellitus. Endocrinologia Diabetes y Nutricion. 2021; 68(4). DOI:10.1016/j.endinu.2020.10.009. PMID:33593709. IF:1,833.
• Fustera VP, Perez AP, Gomez JC, Pedragos AC, Gomez R, Perez P. Executive summary: Updates to the dietary treatment of prediabetes and type 2 diabetes mellitus. REVISTA CLINICA ESPANOLA. 2021; 221(3). DOI:10.1016/j.rce.2020.10.009. PMID:33998467. IF:3,064.
• Genua I, Puig N, Minambres I, Benitez S, Gil P, Grau M, Rivas A, Balague C, Fernandez S, Garcia A, Perez A, Sanchez JL. Changes in the Composition and Function of Lipoproteins after Bariatric Surgery in Patients with Severe Obesity. Journal of Clinical Medicine. 2021; 10(8):1716. DOI:10.3390/jcm10081716. PMID:33923393. IF:4,964.
• Genua I, Tuneu L, Ramos A, Stantonyonge N, Caimari F, Balagué C, Fernández-Ananin S, Sánchez-Quesada JL, Pérez A, Miñambres I. Effectiveness of Bariatric Surgery in Patients with the Metabolically Healthy Obese Phenotype. Obesity Surgery. 2021;31(2):517-522. DOI:10.1007/s11695-020-04967-6. PMID: 32915359. IF:3,479.
• Gimenez G, Franch J, Ortega E, Mata M, Goday A, Real J, Rodriguez A, Vlacho B, Mauricio D. Clinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain). Journal of Clinical Medicine. 2021; 10(7):1536. DOI:10.3390/jcm10071536. PMID:33917523. IF:4,964.
• Gimeno JA, Rodriguez L, Anguita M, Barrios V, Muniz J, Perez A. Association of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes. Journal of Clinical Medicine. 2021; 10(20):4634. DOI:10.3390/jcm10204634. PMID:34682756. IF:4,964.
• Granado M, Martinez D, Martinez M, Doria M, Alcubierre N, Valls J, Julve J, Verdu J, Mauricio D. Psychometric Validation of the Cardiff Wound Impact Schedule Questionnaire in a Spanish Population with Diabetic Foot Ulcer. Journal of Clinical Medicine. 2021; 10(17):4023. DOI:10.3390/jcm10174023. PMID:34501471. IF:4,964.
• Gras JR, Rodriguez F, Gomez B, Cubero JM, Martel M, Granell E, Lopez M, Montserrat JR, Massegur H. Management of Patients With Graves Orbitopathy Using Endonasal Endoscopic Techniques. JOURNAL OF CRANIOFACIAL SURGERY. 2021; 32(4). DOI:10.1097/SCS.0000000000007107. PMID:33170828. IF:1,172.
• Hernandez M, Mauricio D. Latent Autoimmune Diabetes in Adults: A Review of Clinically Relevant Issues. Advances in Experimental Medicine and Biology. 2021; 1307. DOI:10.1007/5584_2020_533. PMID:32424495. IF:3,650.
• Iglesias P, Peiro I, Biagetti B, Paja M, Cobo DA, Gomez CG, Mateu M, Genua I, Majem M, Riudavets M, Gavira J, Lamas C, Pombo AF, Guerrero F, Villabona C, Agricola JMC, Webb SM, Diez JJ. Immunotherapy-induced isolated ACTH deficiency in cancer therapy. ENDOCRINE-RELATED CANCER. 2021; 28(12). DOI:10.1530/ERC-21-0228. PMID:34609950. IF:5,900.
• Immanuel J, Simmons D, Harreiter J, Desoye G, Corcoy R, Adelantado JM, Devlieger R, Lapolla A, Dalfra MG, Bertolotto A, Wender-Ozegowska E, Zawiejska A, Dunne FP, Damm P, Mathiesen ER, Jensen DM, Andersen LLT, Hill DJ, Jelsma JGM, Kautzky-Willer A, Galjaard S, Snoek FJ, van Poppel MNM. Metabolic phenotypes of early gestational diabetes mellitus and their association with adverse pregnancy outcomes. Diabetic Medicine. 2021;38(2):e14413. DOI:10.1111/dme.14413. PMID: 32991758. IF:4,213.
• Julián MT, Pera G, Soldevila B, Caballería L, Julve J, Puig C, Morillas R, Torán P, Expósito C, Puig M, Castelblanco E, Franch J, Cusi K, Mauricio D, Alonso N. Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: A population-based study. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2021; 184(4). DOI:10.1530/EJE-20-1240. PMID:33606661. IF:6,664 (Q1/D2).
• Lázaro Martínez JL, Almaraz MC, Álvarez Hermida Á, Blanes Mompó I, Escudero Rodríguez JR, García Morales EA, March García JR, Rivera San Martín G, Rodríguez Sáenz de Buruaga V, Rosendo Fernández JM, Rubio García JA, Mauricio D. Consensus document on actions to prevent and to improve the management of diabetic foot in Spain. Endocrinologia Diabetes y Nutricion. 2021;68(7):509-513. DOI:10.1016/j.endien.2020.08.016. PMID: 34863416. IF:1,833.
• Lima RA, Desoye G, Simmons D, Devlieger R, Galjaard S, Corcoy R, Adelantado JM, Dunne F, Harreiter J, Kautzky-Willer A, Damm P, Mathiesen ER, Jensen DM, Andersen LT, Tanvig M, Lapolla A, Dalfra MG, Bertolotto A, Manta U, Wender-Ozegowska E, Zawiejska A, Hill DJ, Snoek FJ, Jelsma JGM, van Poppel M. The importance of maternal insulin resistance throughout pregnancy on neonatal adiposity. PAEDIATRIC AND PERINATAL EPIDEMIOLOGY. 2021;35(1):83-91. DOI:10.1111/ppe.12682. PMID: 32352590. IF:3,103.
• Magliano DJ, Chen L, Islam RM, Carstensen B, Gregg EW, Pavkov ME, Andes LJ, Balicer R, Baviera M, Boersma E, Booth GL, Chan JCN, Chua YX, Fosse S, Fuentes S, Gulseth HL, Gurevicius R, Ha KH, Hird TR, Jermendy G, Khalangot MD, Kim DJ, Kiss Z, Kravchenko VI, Leventer M, Lin CY, Luk A, Mata M, Mauricio D, Nichols GA, Nielen MM, Pang D, et al. Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings. Lancet Diabetes & Endocrinology. 2021; 9(4). DOI:10.1016/S2213-8587(20)30402-2. PMID:33636102. IF:44,867.
• Martinez JLL, Almaraz MC, Hermida AA, Mompo IB, Rodriguez J, Morales E, Garcia JRM, San Martin GR, de Buruaga VRS, Fernandez JMR, Garcia J, Mauricio D. Consensus document on actions to prevent and to improve the management of the diabetic foot in Spain. Endocrinologia Diabetes y Nutricion. 2021; 68(7). DOI:10.1016/j.endinu.2020.08.001. PMID:33160948. IF:1,833.
• Mata M, Franch J, Real J, Vlacho B, Gomez A, Mauricio D. Evaluation of clinical and antidiabetic treatment characteristics of different sub-groups of patients with type 2 diabetes: Data from a Mediterranean population database. Primary Care Diabetes. 2021; 15(3). DOI:10.1016/j.pcd.2021.02.003. PMID:33602606. IF:2,567.
• Mateu M, Corcoy R. Labetalol and hypoglycaemia unawareness: two case reports and considerations about its use as an antihypertensive drug for women with diabetes and pregnancy. ACTA DIABETOLOGICA. 2021; 58(6). DOI:10.1007/s00592-021-01688-9. PMID:33638710. IF:4,087.
• Mauricio D, Gourdy P, Bonadonna RC, Freemantle N, Bigot G, Mauquoi C, Ciocca A, Bonnemaire M, Muller D. Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis. Diabetes Therapy. 2021; 12(4). DOI:10.1007/s13300-021-01031-z. PMID:33751403. IF:3,595.
• Mauricio D, Westerbacka J, Nicholls C, Wu J, Gupta R, Eliasson B. How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real-world setting? DIABETES OBESITY & METABOLISM. 2021;23(3):838-843. DOI:10.1111/dom.14264. PMID: 33236461. IF:6,408.
• Meek CL, Corcoy R, Asztalos E, Kusinski LC, Lopez E, Feig DS, Murphy HR, CONCEPTT GRP. Which growth standards should be used to identify large- and small-for-gestational age infants of mothers with type 1 diabetes? A pre-specified analysis of the CONCEPTT trial. BMC Pregnancy and Childbirth. 2021; 21(1):96. DOI:10.1186/s12884-021-03554-6. PMID:33514342. IF:3,105.
• Meek CL, Tundidor D, Feig DS, Yamamoto JM, Scott EM, Ma D, Halperin JA, Murphy HR, Corcoy R. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes. DIABETES CARE. 2021; 44(3). DOI:10.2337/dc20-2360. PMID:33495292. IF:17,152.
• Mendez KA, Rodriguez E, Sebastian D, Blanco R, Camacho M, Nan MN, Diarte E, Mato E, Lope S, Roglans N, Laguna JC, Alonso N, Mauricio D, Zorzano A, Villarroya F, Villena JA, Blanco F, Julve J. Nicotinamide Protects Against Diet-Induced Body Weight Gain, Increases Energy Expenditure, and Induces White Adipose Tissue Beiging. MOLECULAR NUTRITION & FOOD RESEARCH. 2021; 65(11):2100111. DOI:10.1002/mnfr.202100111. PMID:33870623. IF:6,575.
• Minambres I, Sanchez J, Cuixart G, Sanchez A, Sarroca J, Perez A. Characterization of the hypertriglyceridemic waist phenotype in patients with type 2 diabetes mellitus in Spain: an epidemiological study. REVISTA CLINICA ESPANOLA. 2021; 221(10). PMID:34839890. IF:3,064.
• Nan MN, Roig R, Martinez S, Rives J, Urgell E, Espinos JJ, Tirado M, Carreras G, Aulinas A, Webb SM, Corcoy R, Blanco F, Tondo M. Comprehensive Genetic Testing of CYP21A2: A Retrospective Analysis in Patients with Suspected Congenital Adrenal Hyperplasia. Journal of Clinical Medicine. 2021; 10(6):1183. DOI:10.3390/jcm10061183. PMID:33809035. IF:4,964.
• Ortega E, Corcoy R, Gratacos M, Claramunt FXC, Mata M, Puig R, Real J, Vlacho B, Castelblanco E, Domingo P, Khunti K, Franch J, Mauricio D. Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study. BMJ Open. 2021; 11(7):e051237. DOI:10.1136/bmjopen-2021-051237. PMID:34301668. IF:3,006.
• Oyaguez I, Gomez F, Artola S, Carrasco FJ, Carretero J, Garcia J, Gomez R, Merino JF, Perez A. Cost Analysis of FreeStyle Libre(R) 2 System in Type 2 Diabetes Mellitus Population. Diabetes Therapy. 2021; 12(9). DOI:10.1007/s13300-021-01064-4. PMID:33948909. IF:3,595.
• Paz-Graniel I, Babio N, Becerra-Tomás N, Toledo E, Camacho-Barcia L, Corella D, Castañer-Niño O, Romaguera D, Vioque J, Alonso-Gómez ÁM, Wärnberg J, Martínez JA, Serra-Majem L, Estruch R, Tinahones FJ, Fernandez-Aranda F, Lapetra J, Pintó X, Tur JA, García-Rios A, Bueno-Cavanillas A, Gaforio JJ, Matía-Martín P, Daimiel L, Sánchez VM, Vidal J, et al.; PREDIMED-Plus Investigators [Perez A]. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population. EUROPEAN JOURNAL OF NUTRITION. 2021;60(5):2381-2396. DOI:10.1007/s00394-020-02415-w. PMID: 33125576. IF:4,865.
• Purroy F, Sanchez E, Lecube A, Arque G, Vicente M, Mauri G, Torreguitart N, Hernandez M, Barbe F, Fernandez E, Pamplona R, Farras C, Mauricio D, Bermudez M. Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project. Frontiers in Neurology. 2021; 12:785640. DOI:10.3389/fneur.2021.785640. PMID:34970215. IF:4,086.
• Real J, Vlacho B, Ortega E, Valles JA, Mata M, Castelblanco E, Wittbrodt ET, Fenici P, Kosiborod M, Mauricio D, Franch J. Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia. Cardiovascular Diabetology. 2021; 20(1):139. DOI:10.1186/s12933-021-01323-5. PMID:34243779. IF:8,949.
• Revilla G, Cedo L, Tondo M, Moral A, Perez JI, Corcoy R, Lerma E, Fuste V, Reddy TS, Blanco F, Mato E, Escola JC. LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies. SEMINARS IN CANCER BIOLOGY. 2021; 73. DOI:10.1016/j.semcancer.2020.11.012. PMID:33249202. IF:17,012.
• Rojo MI, Castelblanco E, Real J, Hernandez M, Falguera M, Amigo N, Julve J, Alonso N, Franch J, Granado M, Mauricio D. Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area. Nutrients. 2021; 13(12):4369. DOI:10.3390/nu13124369. PMID:34959921. IF:6,706.
• Rotllan N, Camacho M, Tondo M, Diarte E, Canyelles M, Mendez KA, Benitez S, Alonso N, Mauricio D, Escola JC, Blanco F, Julve J. Therapeutic Potential of Emerging NAD plus -Increasing Strategies for Cardiovascular Diseases. Antioxidants. 2021; 10(12):1939. DOI:10.3390/antiox10121939. IF:7,675.
• Sampedro F, Stantonyonge N, Martínez-Horta S, Nan N, Camacho V, Chico A. Increased cerebral FDG-PET uptake in type 1 diabetes patients with impaired awareness of hypoglycaemia. JOURNAL OF NEUROENDOCRINOLOGY. 2021;33(1):e12910. DOI:10.1111/jne.12910. PMID: 33176042. IF:3,870.
• Sanchez M, Sanchez E, Bermudez M, Torres G, Farras C, Pamplona R, Castro E, Valdivielso JM, Purroy F, Martinez M, Godoy P, Mauricio D, Fernandez E, Hernandez M, Rius F, Lecube A. Clinical Usefulness of Anthropometric Indices to Predict the Presence of Prediabetes. Data from the ILERVAS Cohort. Nutrients. 2021; 13(3):1002. DOI:10.3390/nu13031002. PMID:33808883. IF:6,706.
• Sorensen AE, van MNM, Desoye G, Damm P, Simmons D, Jensen DM, Dalgaard LT, Corcoy R, DALI Core Investigator GRP. The Predictive Value of miR-16,-29a and-134 for Early Identification of Gestational Diabetes: A Nested Analysis of the DALI Cohort. Cells. 2021; 10(1):170. DOI:10.3390/cells10010170. PMID:33467738. IF:7,666.
• Stantonyonge N, Martinez S, Sampedro F, Sanchez MB, Chico A. Defective involuntary attention to novelty in type 1 diabetes and impaired awareness of hypoglycaemia. DIABETES RESEARCH AND CLINICAL PRACTICE. 2021; 177:108898. DOI:10.1016/j.diabres.2021.108898. PMID:34098058. IF:8,180.
• Stantonyonge N, Sampedro F, Mendez J, Martinez S, Chico A, Gomez B. Structural Gray and White Matter Differences in Patients With Type 1 Diabetes and Impaired Awareness of Hypoglycemia. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2021; 106(2). DOI:10.1210/clinem/dgaa832. PMID:33180907. IF:6,134.
• Teis A, Cediel G, Amigo N, Julve J, Aranyo J, Andres J, Puig C, Castelblanco E, Gual F, Ferrer E, Vallejo N, Junca G, Lopez J, De Antonio M, Domingo M, Santiago E, Codina P, Mauricio D, Lupon J, Alonso N, Bayes A. Particle size and cholesterol content of circulating HDL correlate with cardiovascular death in chronic heart failure. Scientific Reports. 2021; 11(1):3141. DOI:10.1038/s41598-021-82861-6. PMID:33542459. IF:4,996.
• Tundidor D, Meek CL, Yamamoto J, Martinez C, Gich I, Feig DS, Murphy HR, Corcoy R. Continuous Glucose Monitoring Time-in-Range and HbA(1c) Targets in Pregnant Women with Type 1 Diabetes. Diabetes Technology & Therapeutics. 2021; 23(10). DOI:10.1089/dia.2021.0073. PMID:33945304. IF:7,337.
• Vlacho B, Mata M, Mundet X, Valles JA, Real J, Farre M, Cos X, Khunti K, Mauricio D, Franch J. Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study. Frontiers in Endocrinology. 2021; 12:708372. DOI:10.3389/fendo.2021.708372. PMID:34335477. IF:6,055.
• Vlacho B, Mundet X, Mata M, Valles JA, Real J, Farre M, Cos FX, Khunti K, Mauricio D, Franch J. Analysis of the effectiveness of second oral glucose-lowering therapy in routine clinical practice from the mediterranean area: A retrospective cohort study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2021; 171:108616. DOI:10.1016/j.diabres.2020.108616. PMID:33310172. IF:8,180.